BIOMAT Database Logo BIOMAT Database Logo

Peripheral blood stem cells for allografting. 1995

J Goldman

UI MeSH Term Description Entries
D006086 Graft vs Host Disease The clinical entity characterized by anorexia, diarrhea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the GRAFT VS HOST REACTION. Graft-Versus-Host Disease,Homologous Wasting Disease,Runt Disease,Graft-vs-Host Disease,Disease, Graft-Versus-Host,Disease, Graft-vs-Host,Disease, Homologous Wasting,Disease, Runt,Diseases, Graft-Versus-Host,Diseases, Graft-vs-Host,Graft Versus Host Disease,Graft-Versus-Host Diseases,Graft-vs-Host Diseases
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014184 Transplantation, Homologous Transplantation between individuals of the same species. Usually refers to genetically disparate individuals in contradistinction to isogeneic transplantation for genetically identical individuals. Transplantation, Allogeneic,Allogeneic Grafting,Allogeneic Transplantation,Allografting,Homografting,Homologous Transplantation,Grafting, Allogeneic
D016179 Granulocyte Colony-Stimulating Factor A glycoprotein of MW 25 kDa containing internal disulfide bonds. It induces the survival, proliferation, and differentiation of neutrophilic granulocyte precursor cells and functionally activates mature blood neutrophils. Among the family of colony-stimulating factors, G-CSF is the most potent inducer of terminal differentiation to granulocytes and macrophages of leukemic myeloid cell lines. Colony-Stimulating Factor, Granulocyte,G-CSF,Myeloid Growth Factor,Colony Stimulating Factor, Granulocyte,Factor, Granulocyte Colony-Stimulating,Factor, Myeloid Growth,Granulocyte Colony Stimulating Factor,Growth Factor, Myeloid
D018380 Hematopoietic Stem Cell Transplantation Transfer of HEMATOPOIETIC STEM CELLS from BONE MARROW or BLOOD between individuals within the same species (TRANSPLANTATION, HOMOLOGOUS) or transfer within the same individual (TRANSPLANTATION, AUTOLOGOUS). Hematopoietic stem cell transplantation has been used as an alternative to BONE MARROW TRANSPLANTATION in the treatment of a variety of neoplasms. Stem Cell Transplantation, Hematopoietic,Transplantation, Hematopoietic Stem Cell

Related Publications

J Goldman
The use of mobilized peripheral blood stem cells from normal donors for allografting.
January 1997, Stem cells (Dayton, Ohio),
J Goldman
Blood stem cell allografting.
November 1995, Current opinion in hematology,
J Goldman
Peripheral blood stem cells for autografting.
January 1997, Annual review of medicine,
J Goldman
[Peripheral blood stem cells].
October 1996, Hematology and cell therapy,
J Goldman
Peripheral blood stem cells for allogeneic transplantation.
April 1994, Bone marrow transplantation,
J Goldman
Peripheral blood stem cells for allogeneic transplantation.
November 1996, Bone marrow transplantation,
J Goldman
Allografting of peripheral blood stem cell mobilized from a donor developing herpes zoster virus infection.
October 2002, American journal of hematology,
J Goldman
G-CSF-induced mobilization of peripheral blood stem cells for allografting: comparative study of daily single versus divided dose of G-CSF.
August 1997, International journal of hematology,
J Goldman
Clinical use for expanded peripheral blood stem cells.
January 1999, Bailliere's best practice & research. Clinical haematology,
J Goldman
New agents for mobilizing peripheral blood stem cells.
August 2009, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis,
Copied contents to your clipboard!